Biomedical scientists have found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut’s epithelium.
Drug decreases gut leakiness associated with ulcerative colitis
Biomedical scientists have found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut’s epithelium.